Billich A - Search Results

1

NBD-labeled derivatives of the immunomodulatory drug FTY720 as tools for metabolism and mode of action studies.

Ettmayer P, Baumruker T, Guerini D, Mechtcheriakova D, Nussbaumer P, Streiff MB, Billich A. Ettmayer P, et al. Among authors: billich a. Bioorg Med Chem Lett. 2006 Jan 1;16(1):84-7. doi: 10.1016/j.bmcl.2005.09.038. Epub 2005 Oct 19. Bioorg Med Chem Lett. 2006. PMID: 16236505

2

Fluorescence-labeled sphingosines as substrates of sphingosine kinases 1 and 2.

Ettmayer P, Billich A, Baumruker T, Mechtcheriakova D, Schmid H, Nussbaumer P. Ettmayer P, et al. Among authors: billich a. Bioorg Med Chem Lett. 2004 Mar 22;14(6):1555-8. doi: 10.1016/j.bmcl.2003.12.099. Bioorg Med Chem Lett. 2004. PMID: 15006402

3

Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

Zemann B, Kinzel B, Müller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, Billich A. Zemann B, et al. Among authors: billich a. Blood. 2006 Feb 15;107(4):1454-8. doi: 10.1182/blood-2005-07-2628. Epub 2005 Oct 13. Blood. 2006. PMID: 16223773 Free article.

4

Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.

Hanessian S, Charron G, Billich A, Guerini D. Hanessian S, et al. Among authors: billich a. Bioorg Med Chem Lett. 2007 Jan 15;17(2):491-4. doi: 10.1016/j.bmcl.2006.10.014. Epub 2006 Oct 10. Bioorg Med Chem Lett. 2007. PMID: 17070046

5

FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis.

Baumruker T, Billich A, Brinkmann V. Baumruker T, et al. Among authors: billich a. Expert Opin Investig Drugs. 2007 Mar;16(3):283-9. doi: 10.1517/13543784.16.3.283. Expert Opin Investig Drugs. 2007. PMID: 17302523 Review.

6

FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3.

Mechtcheriakova D, Wlachos A, Sobanov J, Bornancin F, Zlabinger G, Baumruker T, Billich A. Mechtcheriakova D, et al. Among authors: billich a. FEBS Lett. 2007 Jun 26;581(16):3063-8. doi: 10.1016/j.febslet.2007.05.069. Epub 2007 Jun 4. FEBS Lett. 2007. PMID: 17555747 Free article.

7

Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.

Billich A, Bornancin F, Dévay P, Mechtcheriakova D, Urtz N, Baumruker T. Billich A, et al. J Biol Chem. 2003 Nov 28;278(48):47408-15. doi: 10.1074/jbc.M307687200. Epub 2003 Sep 16. J Biol Chem. 2003. PMID: 13129923 Free article.

8

4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase.

Nussbaumer P, Bilban M, Billich A. Nussbaumer P, et al. Among authors: billich a. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2093-5. doi: 10.1016/s0960-894x(02)00381-5. Bioorg Med Chem Lett. 2002. PMID: 12127511

9

2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.

Nussbaumer P, Lehr P, Billich A. Nussbaumer P, et al. Among authors: billich a. J Med Chem. 2002 Sep 12;45(19):4310-20. doi: 10.1021/jm020878w. J Med Chem. 2002. PMID: 12213072

10

Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase.

Nussbaumer P, Geyl D, Horvath A, Lehr P, Wolff B, Billich A. Nussbaumer P, et al. Among authors: billich a. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3673-7. doi: 10.1016/j.bmcl.2003.08.019. Bioorg Med Chem Lett. 2003. PMID: 14552755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters